Nov 13 (Reuters) - Entero Therapeutics Inc ( ENTO ):
* ENTERO THERAPEUTICS ANNOUNCES PROPOSED REVERSE MERGER WITH
JOURNEY THERAPEUTICS, A CLINICAL STAGE, FIRST-IN-CLASS,
NEXT-GENERATION ADC-RIVALLING NANO-IMMUNOCONJUGATES
BIOPHARMACEUTICAL COMPANY
* ENTERO THERAPEUTICS INC ( ENTO ) - JOURNEY SHAREHOLDERS TO ACQUIRE
99% OF
ENTERO EQUITY
* ENTERO THERAPEUTICS INC ( ENTO ) - COMBINED COMPANY TO OPERATE AS
JOURNEY
THERAPEUTICS AND APPLY FOR NASDAQ LISTING
Source text:
Further company coverage: